Drawing for MAZIE

USPTO serial 90838056

MAZIE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SONNEBORN, TRICIA L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MAZIE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nancy Sabarra

Nancy Sabarra FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 WEST 42ND STREET, 17TH FLOORNEW YORK, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
001Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research useACTIVE—
005Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticalsACTIVE—
042Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccinesACTIVE—
044Medical services; medical information; providing a website featuring medical informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 6, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 6, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 26, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 26, 2025EX5GSOU EXTENSION 5 GRANTED—
Nov 24, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 23, 2025EXT5SOU EXTENSION 5 FILED—
May 17, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 16, 2025EX4GSOU EXTENSION 4 GRANTED—
May 16, 2025EXT4SOU EXTENSION 4 FILED—
May 16, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 11, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 11, 2024EX3GSOU EXTENSION 3 GRANTED—
Dec 9, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 12, 2024EXT3SOU EXTENSION 3 FILED—
Nov 12, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 23, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 22, 2024EX2GSOU EXTENSION 2 GRANTED—
May 22, 2024EXT2SOU EXTENSION 2 FILED—
May 22, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 23, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 21, 2023EX1GSOU EXTENSION 1 GRANTED—
Nov 21, 2023EXT1SOU EXTENSION 1 FILED—
Nov 21, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 30, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 4, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 4, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 1, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 1, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Mar 1, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 1, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 1, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 6, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 6, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 31, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 31, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 31, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 3, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 3, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 3, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 4, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2022DOCKASSIGNED TO EXAMINER—
Sep 21, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 23, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance